Shares of Cytori Therapeutics (CYTX) are up 25% in pre-market trading after the company announced this morning that its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution System by the State FDA of the People’s Republic of China. Cytori Therapeutics said that this regulatory clearance officially makes its Celution System […]
View the full post at: Cytori (CYTX) Shares Spike on Regulatory Clearance in China